Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Cellular, Molecular, and Tumor Biology 84: DNA Methylation: New Genes

Transcription Factor AP-1 is required for the proliferation of pancreatic cancer cells and its constitutive activation is dependent on PI 3-kinase-mediated signals

Takayuki Asano, Yixin Yao, David G. Menter, James L. Abbruzzese and Shrikanth A. Reddy
Takayuki Asano
M. D. Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yixin Yao
M. D. Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David G. Menter
M. D. Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James L. Abbruzzese
M. D. Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shrikanth A. Reddy
M. D. Anderson Cancer Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published April 2004
  • Article
  • Info & Metrics
Loading
Proc Amer Assoc Cancer Res, Volume 45, 2004

Abstract

4214

Our recent studies have suggested that the transcription factor activator protein-1 (AP-1) is constitutively activated in pancreatic cancer cells. Gel mobility shift assays revealed strong AP-1-binding activities in various serum-starved pancreatic cancer cell lines suggesting that AP-1 activation is constitutive and independent of serum factors. Through a combination of immunoblotting and super-shift analyses, we determined that AP-1 specifically contained phospho-c-Jun (serines 63 and 73), Jun D, Jun B, Fra 1 and Fra 2. Little or no c-Fos or ATF-2 was detectable in the AP-1/DNA complexes. Consistent with these results, two different AP-1-dependent reporter genes were highly induced in pancreatic cancer cells as determined by transient transfection assays. Through stable transfection of a transactivation domain mutant of c-Jun (TAM67), we demonstrate that AP-1 is critical for the proliferation of pancreatic cancer cells both in anchorage-dependent, and -independent conditions. An investigation of the signaling pathways that might be responsible for AP-1 activation in pancreatic cancer cells indicated that multiple signals could be involved. Indeed, while the Jun N-terminal kinase (JNK) was constitutively activated in these cells and responsible for the phosphorylation of c-Jun on serines 63 and 73, phosphatidylinositide 3-kinase (PI 3-kinase) and its mediator Akt were also essential. PI 3-kinase function was required for the transactivation potential of AP-1 but not for its DNA-binding activity. The mechanism by which the transcription factor is regulated by PI 3-kinase in pancreatic cancer cells did not appear to involve changes in the expression or phosphorylation of various AP-1 proteins. Induction of the AP-1 reporter gene could be inhibited, however, by cotransfection with a CREB construct mutated on an Akt-regulated site (Ser133Ala), suggesting that PI 3-kinase regulated AP-1 activity through transcription factor CREB. These and other observations suggest that AP-1 is constitutively activated through specific PI 3-kinase-controlled mechanisms, and that it is essential for the proliferation of pancreatic cancer cells.

  • American Association for Cancer Research
Previous
Back to top
April 2004
Volume 64, Issue 7 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Transcription Factor AP-1 is required for the proliferation of pancreatic cancer cells and its constitutive activation is dependent on PI 3-kinase-mediated signals
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Transcription Factor AP-1 is required for the proliferation of pancreatic cancer cells and its constitutive activation is dependent on PI 3-kinase-mediated signals
Takayuki Asano, Yixin Yao, David G. Menter, James L. Abbruzzese and Shrikanth A. Reddy
Cancer Res April 1 2004 (64) (7 Supplement) 973;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Transcription Factor AP-1 is required for the proliferation of pancreatic cancer cells and its constitutive activation is dependent on PI 3-kinase-mediated signals
Takayuki Asano, Yixin Yao, David G. Menter, James L. Abbruzzese and Shrikanth A. Reddy
Cancer Res April 1 2004 (64) (7 Supplement) 973;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Colorectal carcinomas with sporadic microsatellite instability have lower levels of line-1 methylation in their normal adjacent tissues
  • TLP, a novel modulator of the transforming growth factor-? pathway which regulates Smad3-dependent signaling, is downregulated in a variety of human cancers
  • A new rapid and effective methylation sensitive representational difference analysis
Show more Cellular, Molecular, and Tumor Biology 84: DNA Methylation: New Genes
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement